Research Article

Current Practice and Barriers to an Early Antimicrobial Conversion from Intravenous to Oral among Hospitalized Patients at Jimma University Specialized Hospital: Prospective Observational Study

Table 2

Pattern of diseases and prescribed drugs for intravenous to oral converting practice at Jimma University Specialized Hospital, South West Ethiopia, February–September, 2014 (n=142 ).

CharacteristicsRespondents
N ()

Diagnosis for antimicrobial therapy (n= 142)
 Community acquired Pneumonia(CAP)96(67.6)
 Skin and soft tissue infection14(9.9)
 Community acquired pneumonia + UTI14(9.9)
 Urinary tract infection (UTI)12(8.5)
 Bone and joint infection4(2.8)
 Urinary tract infection + bone and joint infection2(1.4)

Co-morbidity (n=102)
 Cardio vascular disease (CVD)56(54.9)
 Tuberculosis26(25.5)
 Diabetes mellitus12(11.8)
 Human immunodeficiency virus (HIV)2(2.0)
 >1 Co-morbidity6(6.0)

Patients were receiving intravenous antimicrobials (n=142)
 Ceftriaxone106(74.6)
 Chloramphenicol + Cloxacillin16(11.3)
 Ceftazidime4(2.8)
 Ampicillin + Ceftriaxone4(2.8)
 Ceftriaxone + Cloxacillin + Metronidazole4(2.8)
 Cloxacillin + Ceftriaxone2(1.4)
 Gentamicin +Ceftriaxone2(1.4)